SMSNA remains fully committed to holding a successful in-person meeting at the Westin Kierland in Scottsdale, AZ this October. SMSNA’s priority remains the health and well-being of our community. We are working closely with the Westin Kierland and third-party vendors to implement thorough but adaptable COVID-19 safety protocols. These protocols will meet or exceed all recommendations and safety procedures from the CDC, the State of Arizona, and the City of Scottsdale. Our current preparations include but are not limited to the following:
For the safety of all attendees, everyone attending will be required to complete an attestation indicating that they have been fully vaccinated OR, if they are not fully vaccinated, that they will obtain a negative PCR or antigen coronavirus test within 72 hours of their first day at the 2021 SMSNA Annual Fall Scientific Meeting. They should also attest that, regardless of their vaccination status, they will not be attending the meeting if they are ill or have been exposed to COVID-19 within the 14 days preceding the meeting. All attendees will be asked to complete the attestation either as part of registration, or in case already registered through a link provided by us by email. Individuals who do not complete the attestation will not be permitted to enter the meeting.
All meeting attendees will be required to wear a mask, regardless of vaccination status, within the assigned SMSNA meeting spaces of the Westin Kierland. Masks will be available at the registration desk. Hand sanitizing stations will be available throughout the hotel including meeting spaces.
Due to the necessity to continue social distancing, especially while eating, pre-packed food items will be provided for any meals (boxed if possible) which will allow attendees to take their meal at a location outside of the indoor meeting space. The Welcome Reception is scheduled as an indoor and outdoor event, with the food and drinks only offered outside. The SMSNA Foundation event is scheduled as an outdoor event.
The Westin Kierland requires temperature checks for all employees prior to being allowed in the property. They also require all employees to wear a mask. For more information on Marriott’s policy to “travel with confidence during COVID-19” please view their website: https://clean.marriott.com/#service.Marriott is the parent company of the Westin brand of hotels.
SMSNA will continuously evaluate and update our plans and guidelines as new information becomes available and as environmental conditions change. We will continue to share all updates on evolving COVID-19 preparations as we actively work to plan for a healthy and productive event. For the most up to date information, please refer to the SMSNA meeting website.
Registrations are only accepted if this online registration form has been successfully submitted. No registration form is accepted unless accompanied by full payment.
2. Security
When registering through the internet, your personal and payment details are secured and encrypted. The latest encrypting techniques available are used for data transfer.
3. Confirmation/Payment Obligation
As soon as you have finished your personal registration process for the 22nd Annual Fall Scientific Meeting of SMSNA by clicking the "Register Now" button, you enter into a binding agreement with the organization of this meeting. As a result, you accept the payment obligation and the term of payment that comes along with this agreement.
Your registration will be confirmed by e-mail, giving you an overview of the personal details as filled in by you during the registration process. Furthermore, if you select to pay your registration fee by bank transfer or check, you will receive your invoice attached to your confirmation e-mail. A final e-mail will be sent to you once your payment has been received.
In case you fail to meet the term of payment that is applicable to your registration category (early fee or late fee), the organization is entitled to raise your registration fee to the next category (from early fee to regular fee or from regular fee to last-minute fee).
In case the organization has not received your payment before the start of the meeting, entry to the meeting may be refused without your payment obligation being waived.
4. Correspondence Address
For all correspondence regarding the meeting, the organization will use the e-mail address as provided by you during the registration process.
5. Liability
In registering for the congress, the participants agree that neither the SMSNA Board of Directors, Status Plus nor the Meeting Committee or any of their officers, agents, employees, or representatives assume any liability whatsoever.
6. Insurance
Participants are strongly advised to arrange their own travel, health, and cancellation insurance in the unfortunate case of having to cancel the meeting participation and/or travel and/or hotel accomodation because of illness or other (personal) circumstances.
7. Photography/Image Use Policy
SMSNA reserves the right to ue any images, in any media, captured at the meeting and related events, for promotional activities of future SMSNA activities in general. Individuals who do not wish to have their likeness, in any medium, used by SMSNA, must provide written notice to This email address is being protected from spambots. You need JavaScript enabled to view it..
8. Attendee List
For this meeting, a meeting app is available that will contain an attendee list with personal details of everyone that has registered for the meeting. The attendee list is accesible for all meeting attendees, including industry representatives.
9. Industry Sponsored Sessions
Due to compliance regulations, your first name, last name, and e-mail address (e-mail address only of non-EU participants) will be shared with sponsored sessions organizers if you attend an industry sponsored session.
10. Exhibitors
Your first name, last name, and e-mail address (e-email address only for non-EU participants) will be shared with exhibitors if you visit their booth.
11. Currency
All amounts are stated in US Dollars (USD) and must be paid and/or will be collected in USD.
12. Pending Amounts
Any differences (appearing from incorrect application an/or past deadlines) in registration fees will be collected on-site during the meeting.
13. Payment On-Site
On-site payments can be made either in cash or by using a valid credit card.
14. Registration Cancellation & Refund Policy
Cancellation of your registration and refund requests for registration must be submitted in writing to the SMSNA Executive Office before September 1, 2021. All refund requests will be subject to a USD 100.00 processing fee. No refunds will be made on/after September 1, 2021.
Cancellations must be notified as soon as possible in writing (e-mail or letter) to: SMSNA Executive Office 14305 Southcross Dr. Suite 100 Burnsville, MN 55306 USA Phone: (952) 683 1917 Fax: (952) 314 8212 E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. Website: www.smsna.org
Willingham earned her bachelor's degree in English and her PhD in biological sciences at The University of Texas at Austin and completed a postdoctoral fellowship in urology at the University of California-San Francisco. She has taught students of all ages, primarily as a university instructor in scientific writing and biology, focusing on physiology, anatomy, developmental biology, genetics, and general science.
Willingham is the 2014 recipient of the John Maddox Prize for standing up for science, a joint initiative of Nature and the Kohn Foundation, that rewards an individual who has faced difficulty and hostility in the course of promoting sound, evidence-based science on a matter of public interest. She also served on the board of the National Association of Science Writers, for which she chaired the Fairness Committee and co-chaired the membership committee. She is a recipient of an Association of Health Care Journalists fellowship award.
Emily Willingham is author of Phallacy: Life Lessons from the Animal Penis (Avery, 2020) and The Tailored Brain (Basic Books, 2021). Her writing has been published online at the New York Times, Scientific American, Forbes, the San Francisco Chronicle, the Wall Street Journal, Discover, NOVA, Science, and others. She is also co-author with Tara Haelle of the award-winning book, The Informed Parent (Perigee Books/Penguin), and the author of The Complete IG to College Biology. Her writing focuses on the intersection where society, science, and biases meet. She specializes in examining social perspectives on mental health, sexuality and gender, and parenting, with close attention to unconscious motivations and a practical perspective.
She has been struck by lightning once personally, on a ridge in Yellowstone National Park, and also has once been in a car that was struck by lightning and in an airplane that was zapped. In other words, do not stand too near her.
You can find her on Twitter (@ejwillingham), Instagram (@emily.willingham.phd), and Facebook (@ejwillinghamphd).
Join us on Wednesday, November 3 for the Residents Arena, at which the 10 best scoring abstracts submitted by residents to the 22nd Annual Fall Scientific Meeting of SMSNA will be presented by the residents. The 3 best presentations, based on a combination of audience vote (50%) and judges’ scores (50%), will each win $1,000!
Submit Now SMSNA is pleased to announce the 7th annual Essay Prize competition for trainees. Clinical trainees in medicine, surgery and psychology (residents, fellows, medical students, graduate students, nursing students and PA students) are eligible to submit their original research papers, scientific reports, or case reports in sexual medicine for three prizes of $1,500 for the best manuscript in one of the following categories: Male Sexual Health (clinical, surgical, imaging, research) Female Sexual Health (clinical, surgical, imaging, research) Case Report in Sexual Health Manuscripts should also be submitted as abstracts for presentation or poster to the 22nd SMSNA Annual Fall Scientific Meeting in Scottsdale, AZ. Abstract submission is not required for the Case Report in Sexual Health category. Click here for details on Abstract Submission. Manuscripts will be reviewed anonymously and therefore must NOT contain any author(s) or submitting institutions contact information. Any manuscript containing identifying information will not be considered for this prize. Manuscripts will be reviewed by the Essay Prize Review Committee. Winners will be announced at the 22nd SMSNA Annual Fall Scientific Meeting in Scottsdale, AZ. Submission Instructions: Submissions will be accepted by completing the online form by no later than 11:59 pm EDT, September 1, 2021. Submission should contain the following: Category (Male Sexual Health, Female Sexual Health, or Case Report in Sexual Health) Manuscript Title Authors(s) Contact Information Attachment: Manuscript (with no identifying information) including abstracts, tables and figures, and references. Manuscript Rules of Publication: Original Research Original research papers are scientific reports of original clinical or basic research in the field of sexual medicine. As a general guideline, manuscripts should be 3000 words in length; more extensive manuscripts will be considered and judged on merit; however, authors are urged to be as concise as possible. All manuscripts must include an abstract, a maximum of 7 tables and figures (total), and up to 50 references. More may be accepted if justified. Case Report Reports are concise reports of cases, clinical experience, clinical studies, drug trials, adverse effects, or devices related to sexual medicine. Maximum length is 1750 words; no more than 10 references, and 1 figure/table. Other Information: Trainees are encouraged to submit their manuscript to the Journal of Sexual Medicine , Sexual Medicine Open Access , or Sexual Medicine Reviews .
To ensure that article referees or peer reviewers do not know your identity (as author[s] of the abstract being reviewed), you will need to make sure that you remove any information in the actual abstract (including footnotes and acknowledgments) that could identify you and disguise all references to personally identifiable information such as the research institution where your work was carried out. Also exclude references to grants awarded to named persons, refer to your own references in the third person.
Your abstract word count should NOT exceed 500 words.
Structure of your abstract:
Introduction: Describe the background supporting the relevance of the research question.
Objective: State the purpose of the study or investigation.
Methods: State details on study subjects, techniques, and/or observations/anatlytical methods.
Results: Include your main findings, noting statistically significant data.
Conclusions: Summarize principal conclusions, emphasizing new and important aspects.
Use standard abbreviations. Place unusual abbreviations between parentheses (...) after the first appearance of the word.
If an abstract is presented at another meeting which is NOT a North American meeting prior to SMSNA 2021, the SMSNA allows for the abstract to be presented at the SMSNA 2021 Annual Fall Scientific Meeting in Scottsdale.
Acknowledgements: If you do not follow these instructions, your abstract may be declined.
Instructions for Video Abstracts
The below criteria must be met for acceptance of video presentation:
Maximum duration: 8 minutes
File cannot be above 500 MB
Videos must have English captions or narration
Please ensure that your videos protect patient anonymity and integrity
The preferred resolution is 1280x720p (16:9 aspect ratio) HD video
Acceptable file formats are mp4, avi, and mpeg4
PLEASE REMOVE ALL PRODUCT LOGOS/NAMES FROM VIDEO - if a video is submitted with the product name/logo included, the video will be disqualified from consideration.
Irradiation/ED: Clinical Perspective: Minimizing Treatment Related Side Effects of Radiotherapy
Speaker:
Bridget Koontz, MD
8:20 AM - 8:40 AM
Irradiation/ED: Basic Science Perspective: The Impact of Radiation on Neurite Viability
Speaker:
Johanna Hannan, PhD
8:40 AM - 9:00 AM
Diabetes and Obesity/Sexual Dysfunction: Clinical Perspective: The Association Between Diabetes and Sexual Dysfunction and Novel Treatment Strategies (pre-clinical/ clinical e.g. stem cell/SWT)
Speaker:
Wayne Hellstrom, MD
9:00 AM - 9:20 AM
Diabetes and Obesity/Sexual Dysfunction: Basic Science Perspective: Activation of TLR9 Results in Corpus Cavernosum Dysfunction in Mice Fed a High Fat Diet
Speaker:
Clinton Webb, PhD
9:20 AM - 9:40 AM
Diabetes and Obesity/Sexual Dysfunction: Basic Science Perspective: Dyslipidemia Associated Stem Cell Damage as a Potential Factor in Development of ED with Type II Diabetes
Speaker:
Nestor Gonzalez-Cadavid, PhD
9:40 AM - 10:00 AM
Basic Science Insights into the Role of the Vaginal Epithelium in Female Genital Arousal (Dys)function
Speaker:
Sylvia Suadicani, PhD
8:00 AM - 10:00 AM
Kierland Grand Ballroom 2
Instructional Course - Restorative Therapies (requires separate registration)
Moderator:
Gregory Broderick, MD
8:00 AM - 8:20 AM
Shockwave Therapy: The Basic Science
Speaker:
Guiting Lin, MD
8:20 AM - 8:40 AM
Shockwave Therapy for ED - A Review of Devices, Outcomes and Recommendations
Speaker:
Ranjith Ramasamy, MD
8:40 AM - 9:00 AM
Shockwave Therapy for Other Urological Conditions
Speaker:
Gregory Broderick, MD
9:00 AM - 9:20 AM
PRP and Stem Cell Therapy: Where Do We Stand?
Speaker:
Trinity Bivalacqua, MD, PhD
9:20 AM - 9:40 AM
Regenerative Therapies and FSD
Speaker:
Irwin Goldstein, MD
9:40 AM - 10:00 AM
Q&A
8:00 AM - 10:00 AM
Trailblazers Ballroom DE
APP Symposium
Moderator:
Cynthia Bednarchik, DNP, CNP
8:00 AM - 8:05 AM
Welcome
Speaker:
Cynthia Bednarchik, DNP, CNP
8:05 AM - 8:30 AM
Anal Health and Sexual Pleasure: An All-inclusive Discussion of What You Need to Know
Speaker:
Aleece Fosnight, MPS, PA-C
8:35 AM - 9:00 AM
Mental Health and Male Sexual Dysfunction, Impact, Barriers to Care
Speaker:
John Dodge, MPS, PA-C
9:00 AM - 9:30 AM
Racial Health Inequality
Speaker:
Lutricia Harrison, APRN-BC,DNP
9:35 AM - 9:50 AM
Wrap-up Session: Mission, Values, and Objectives for the Advancement and Education of NP/PA
Speaker:
Cynthia Bednarchik, DNP, CNP
10:00 AM - 11:35 AM
Kierland Grand Ballroom 1AB
Basic Science Symposium: The Basic Science / Clinical Science Divide: Bring Down the Wall! - Part 2
Moderators:
Kelvin Davies, MSc, PhD & Clinton Webb, PhD
10:00 AM - 10:20 AM
Prostatectomy/ED: Clinical Perspective: Approaches to Minimize the Nerve Injury that Results in ED Following RP- Does Anything Work?
Speaker:
Trinity Bivalacqua, MD, PhD
10:20 AM - 10:40 AM
Prostatectomy/ED: Basic Science Understanding the Role of Fidgetin-like 2 in CN Growth Following Injury - NOT FOR CE CREDIT
Speaker:
Lisa Baker, PhD, MSc
10:40 AM - 11:00 AM
Prostatectomy/ED: Basic Science Perspective: Sonic Hedgehog Role in Post-surgical Urogenital Complications Associated With Prostatectomy
Speaker:
Carol Podlasek, PhD
11:00 AM - 11:20 AM
The Problem with Patients: Examples of Promising Pre-clinical Treatments for ED that Never Made it Clinically
Moderators:
Sue Goldstein, BA, CCRC, AASECT-CSE & Casey McCraw, MD
2:00 PM - 2:12 PM
Secrets in Couples' Therapy
Speaker:
Daniel Watter, PhD
2:12 PM - 2:24 PM
Providing Care to People Who Engage in Kink: Ethical Reflections
Speakers:
Anna Randall, DHS, LCSW, MPH & Richard Sprott, PhD
2:24 PM - 2:36 PM
Ethical Conundrums in Vasectomies and Vasectomy Reversals
Speaker:
Mary Samplaski, MD
2:36 PM - 2:48 PM
Sexual Side Effects Related to Male Childhood Circumcision: Myth or Reality?
Speaker:
Elias Wehbi, MD, MSc, FRCSC
2:48 PM - 3:00 PM
Global Status of Female Genital Mutilation
Speaker:
Crista Johnson-Akbagwu, MD, MSc, FACOG
3:00 PM - 3:12 PM
Cognitive Impairment (Parkinson's, Dementia, etc) and Sex, a Couple's Perspective
Speaker:
Daniela Wittmann, PhD, LMSW
3:12 PM - 3:24 PM
Long-term Sexual Consequences Following Gender Selection in Children with DSD
Speaker:
Aron Liaw, MD
3:24 PM - 3:30 PM
Q&A
2:00 PM - 3:30 PM
Kierland Grand Ballroom 1AB
Androgens Abstract Session #1
Moderators:
John Mulhall, MD & Alexander Tatem, MD
2:00 PM - 2:05 PM
Long-term Testosterone Therapy Improves Erectile Function and Reduces Mortality in Men with Hypogonadism and Type 2 Diabetes – Updated Results from a Registry Study (#001)
Speaker:
Farid Saad
2:05 PM - 2:10 PM
Subcutaneous Testosterone Enanthate and the Effect of Body Mass Index on Serum Testosterone in Men with Testosterone Deficiency (#002)
Speaker:
Martin Miner, MD
2:10 PM - 2:15 PM
Two-Year Administration Data of an Oral Testosterone Undecanoate (TU) Formulation in Hypogonadal Men (#003)
Speaker:
Stanton Honig
2:15 PM - 2:20 PM
The Effect of Route of Testosterone on Changes in Hematocrit: A Systematic Review and Bayesian Network Meta-Analysis of Randomized Trials (#004)
Speaker:
Sirpi Nackeeran
2:20 PM - 2:25 PM
Continuous Testosterone Therapy with Recombinant FSH & HCG Improves Semen Parameters: A Pilot Study (#005)
Speaker:
Tariq S. Hakky
2:25 PM - 2:30 PM
Effects of Long-term Testosterone Therapy on Erectile Function in Obese Men with Functional Hypogonadism Receiving Long-term Testosterone Therapy- results From a Registry Study (#006)
Speaker:
Ahmad Haider
2:30 PM - 2:35 PM
Prevalence and Severity of Obstructive Sleep Apnea in Men with Polycythemia on Testosterone Therapy (#007)
Speaker:
John Mulhall, MD
2:35 PM - 2:40 PM
Finasteride-Associated Suicide and Depression in Men Treated for Hypogonadism and Impotence (#008)
Speaker:
Kevin Campbell, MD
2:40 PM - 2:45 PM
Safety of Human Chorionic Gonadotropin Monotherapy for Men with Hypogonadal Symptoms and Testosterone >300 ng/dL (#009)
Speaker:
Quinn Rainer
2:45 PM - 2:50 PM
Creatinine: An Inaccurate Measure of Renal Function in Men with Testosterone-Induced Muscle Hypertrophy (#010)
Speaker:
Kevin Campbell, MD
2:50 PM - 2:55 PM
Prevalence and Severity of Obstructive Sleep Apnea (OSA) in Men with Testosterone Deficiency (TD) (#011)
Speaker:
John Mulhall, MD
2:55 PM - 3:00 PM
Early Experience with Subcutaneous Injection of Non-Proprietary Testosterone as an Alternative Approach for Testosterone Replacement (#012)
Erythrocytosis in Subcutaneous Testosterone Replacement Therapy (#014)
Speaker:
Tatum Williamson
3:10 PM - 3:15 PM
Safety of Human Chorionic Gonadotropin Monotherapy for Men with Previous Exogenous Testosterone Use or Replacement Therapy (#015)
Speaker:
Quinn Rainer
3:15 PM - 3:20 PM
Comparison of Prevalence of Polycythemia between Nasal Testosterone Gel vs Intramuscular Testosterone Cypionate: Evaluation of Data from an Ongoing Phase IV, Open-Label, Randomized Clinical Trial (#016)
Speaker:
Parris Diaz
2:00 PM - 3:30 PM
Trailblazers Ballroom DE
Erectile Dysfunction Surgical Abstract Session #1
Moderators:
Sherita King, MD & Allen Morey, MD
2:00 PM - 2:10 PM
To Drain or Not To Drain an Inflatable Penile Prosthesis Implantation? A Multi-institutional Experience Tracking Scrotal Hematoma and Infection Occurrence (#017)
Speaker:
Ahmed Ragheb
2:10 PM - 2:20 PM
Innovative Findings Characterizing the Location and Severity of Postoperative Pain Following Inflatable Penile Prosthesis Surgery Managed With Multimodal Analgesia (#018)
Speaker:
Avery Braun
2:20 PM - 2:30 PM
Evaluation of Gram Positive and Gram Negative Bacteria in a Novel In Vitro Biofilm Model of Penile Prosthesis (#019)
Speaker:
Manish Narasimman
2:30 PM - 2:40 PM
Penile Implant Bacterial Biofilm Profiles Vary by Surgery Indication: An Opportunity to Focus on Peri-operative Care (#020)
Speaker:
Paul Chung
2:40 PM - 2:50 PM
Ectopic Reservoir Placement Following Robotic Prostatectomy: Is it Necessary? (#021)
Speaker:
Matthew Mutter
2:50 PM - 3:00 PM
Drain Volume Output Following IPP Implantation: An Analysis by Surgical Approach (#022)
Speaker:
Michael Tonzi
3:00 PM - 3:10 PM
Does Medicaid Cover Penile Prosthesis Surgery? A State-by-State Analysis (#023)
Speaker:
John Barnard
3:10 PM - 3:20 PM
The Urethral Microbiome During Inflatable Penile Prosthesis Placement (#024)
Speaker:
John Williams
3:20 PM - 3:30 PM
Ethnic Disparities in Penile Prosthesis Surgery: An Analysis of Hispanic Patients (#025)
Speaker:
Alfredo Suarez-Sarmiento, Jr.
3:30 PM - 4:00 PM
Vista Morada Patio
Coffee Break
3:30 PM - 4:00 PM
Foyer - E-poster Station 1
Peyronie's Disease/Priapism E-poster Session
Moderator:
Lawrence Jenkins, MD, MBA
3:30 PM - 3:33 PM
Uncontrolled Diabetes Mellitus is associated with Complications of Peyronie’s Disease (#170)
The Effect of Collagenase Clostridium Histolyticum Injection on the Treatment Patterns of Peyronie’s Disease: An Analysis of Large Health Care System Over 15-year Period (#171)
Differences in Patient Characteristics and Surgical Outcomes in Inpatient vs Outpatient Surgery for Peyronie’s Disease: Contemporary Data from the National Surgical Quality Improvement Program Database (#177)
Treatment of Peyronie’s Disease Patients with Collagenase Clostridium Histolyticum: Clinical Significance and Outcomes (#178)
Speaker:
Ahmad Al-Qudimat
3:57 PM - 4:00 PM
Safety and Feasibility of Platelet-Rich Plasma Injections for Peyronie’s Disease: Update From a Single-center Double-blind Placebo-controlled Randomized Trial (#179)
Perioperative Morbidity of Feminizing Gender Affirmation Surgery: Analysis of the National Surgical Quality Improvement Program (NSQIP) Database (#181)
Systematic Evaluation of YouTube Content on Testosterone Therapy: The Proliferation of Bro-Science (#031)
Speaker:
Zhenyue Huang
5:00 PM - 5:10 PM
Testosterone Replacement Therapy (TRT) is not Associated with a Higher Risk of DVT: Retrospective Analysis of US Claims Data (#032)
Speaker:
Eduardwil Hernandez-Vegas
5:10 PM - 5:20 PM
Persistent Testosterone Suppression After Cessation of Androgen Deprivation Therapy for Localized Prostate Cancer (#033)
Speaker:
Ruben Blachman Braun
5:20 PM - 5:30 PM
Utility of Directly Measured Free Testosterone in Predicting Benefit of Testosterone Therapy in Men with Hypogonadal Symptoms and Normal Total Testosterone (#034)
Speaker:
Nivetha Chandrasekaran
4:00 PM - 5:30 PM
Trailblazers Ballroom DE
Female Sexual Function Abstract Session
Moderators:
Noel Kim, PhD & Tami Rowen, MD, MS, FACOG
4:00 PM - 4:10 PM
Ethnic Underrepresentation in Validation of Female Sexual Dysfunction Questionnaires (#035)
Speaker:
Carissa Redmon
4:10 PM - 4:20 PM
The Impact of Social Determinants of Health on Female Sexual Function (#036)
Speaker:
Jonathan Davila
4:20 PM - 4:30 PM
Determining Borders of Surgical Excision of the Vestibule Based on Positive CD117 and PGP9.5 Staining of Mast Cells in Women with Neuroproliferative Vestibulodynia (#037)
Speaker:
Irwin Goldstein, MD
4:30 PM - 4:40 PM
The 12:00 Region of the Vestibule: Often Overlooked during Examination and Treatment of Women with Entrance Dyspareunia (#038)
Speaker:
Alyssa Yee
4:40 PM - 4:50 PM
Onset of Flibanserin Treatment Effect in Postmenopausal Women Assessed by Subdomain Scores of the Female Sexual Function Index (FSFI) (#039)
Speaker:
James Simon
4:50 PM - 5:00 PM
Female Genitalia in Pornography: The Source of Labiaplasty Trends? (#040)
Speaker:
Alexandra Dubinskaya
5:00 PM - 5:10 PM
Sexual Activities and Fear-related Reasons for Avoiding Sexual Activities in Early Pregnancy: A Cross-sectional Study (#041)
Speaker:
Chi Thanh Phan
5:10 PM - 5:20 PM
Systemic Estradiol Menopause Management: Return to the Old-Fashioned Way (#042)
Speaker:
Sue Goldstein, BA, CCRC, AASECT-CSE
5:20 PM - 5:30 PM
A Pilot Study of Pre-Operative Vestibular Low Intensity Shockwave Therapy to Decrease Opioid Use Post-Vestibulectomy (#043)
Speaker:
Alyssa Yee
5:30 PM - 6:30 PM
Kierland Grand Ballroom 2
Presidential Lecture and Opening Ceremony
5:30 PM - 6:00 PM
Presidential Lecture: The Impact of the Pandemia for Sexual Medicine
Speaker:
Serge Carrier, MD, FRCS(C), MMgmt
6:30 PM - 8:00 PM
Vista Morada Patio
Welcome Reception
Friday, October 22, 2021
7:00 AM - 8:00 AM
Kierland Grand Ballroom 4
Industry Sponsored Breakfast Symposium
8:00 AM - 10:00 AM
Kierland Grand Ballroom 2
What's the Buzz? Sexual Medicine in 2021
Moderators:
Nelson Bennett, MD, FACS & Faysal Yafi, MD, FRCSC
8:00 AM - 8:05 AM
Urology Care Foundation Update
Speaker:
Harris M. Nagler, MD, FACS
8:05 AM - 8:20 AM
8th Annual Robert J. Krane Lecture - Priapism: From Bench to Bedside and Back
Speaker:
Arthur Burnett, MD
8:20 AM - 8:29 AM
A Summary of the New AUA Disorders of Ejaculation Guidelines
Speaker:
Alan Shindel, MD
8:29 AM - 8:38 AM
A Summary of the New AUA Priapism Guidelines
Speaker:
Trinity Bivalacqua, MD, PhD
8:38 AM - 8:47 AM
Review of SMSNA Position Statement on Restorative Therapies
Speaker:
Trinity Bivalacqua, MD, PhD
8:47 AM - 8:56 AM
Vacuum Therapy for Penile Rehabilitation: Science or Fiction?
Speaker:
Run Wang, MD, FACS
8:56 AM - 9:05 AM
Use of Testosterone Therapy for Women with HSDD
Speaker:
Sharon Parish, MD, NCMP
9:05 AM - 9:14 AM
Insurance Coverage Variation with Advanced Erectile Dysfunction Treatment: An American Perspective
Speaker:
Matthew Ziegelmann, MD
9:14 AM - 9:23 AM
Cost-effectiveness of Sexual Healthcare - International Perspective
Speaker:
Rupin Shah, MD
9:23 AM - 9:32 AM
The Impact of Physician Productivity Models on Access to Sexual Medicine
Speaker:
James Dupree, MD, MPH
9:32 AM - 9:41 AM
COVID and Direct-to-consumer Online Treatments for Male Sexual Dysfunction
Speaker:
Aaron Spitz, MD
9:41 AM - 9:50 AM
Surgical Education During a Pandemic: Limitations, Opportunities, and Lessons
Speaker:
Brian Christine, MD
9:50 AM - 10:00 AM
Q&A
10:00 AM - 10:30 AM
Vista Morada Patio
Coffee Break
10:00 AM - 10:30 AM
Foyer - E-poster Station 1
Cancer Survivorship/Mental Health/Miscellaneous E-poster Session
Moderator:
Alan Shindel, MD
10:00 AM - 10:03 AM
Testicular Pain – Not Always What it Seems: A Cross-sectional Assessment of Patients Presenting for Chronic Scrotal Content Pain at a Tertiary Care Center (#187)
Sexual Function after Burn Injury: “The Bystander Effect” and Other Results from a Survey of Active Medical Providers from the Canadian Burn Association (#193)
IIEF-EF Improvements are more Pronounced with Nutraceuticals Compared to Placebo Medications: A Systematic Review and Meta-analysis (#196)
Speaker:
Mark Arthur
10:03 AM - 10:06 AM
How Long Does it Take to Achieve Maximal Improvements of Erectile Function in Men with Functional Hypogonadism Receiving Long-term Testosterone Therapy? Results from a Registry Study (#197)
A Free Listing Assessment of Sexual Function and Relationships for Penile Prosthesis and Intracavernosal Injection Therapy for Erectile Dysfunction (#199)
Leptin-LEPR-Desert Hedgehog Signaling Induced Leydig Stem Cells Differentiation in Testis is Modulated by EMT Inducing Transcription Factors which Binds to LEPR (#045)
Speaker:
Kajal Khodamoradi
1:50 PM - 2:00 PM
Intracavernous Injection of Botulinum Toxin may Improve Erectile Function in a Bilateral Cavernous Nerve Injury Animal Model (#046)
Speaker:
Jeffrey Campbell, MD
2:00 PM - 2:10 PM
Synergy Between Sildenafil and Topically Delivered Nitric-oxide in Eliciting an Erectile Response in a Rat Model of Radical Prostatectomy (#047)
Speaker:
Moses Tar, MD
2:10 PM - 2:20 PM
Tumor Necrosis Factor- α (TNF-α) and Rho-Associated Kinase 2 (ROCK2) Inhibitors Improve Erectile Function in a Bilateral Cavernous Nerve Injury Rat Model (#048)
Speaker:
James Liu
2:20 PM - 2:25 PM
Endogenous Effects of Leptin on Leydig Stem Cell Differentiation through Desert Hedgehog Signaling Pathway (#049)
Speaker:
Alexandra Dullea
2:25 PM - 2:30 PM
Dual Strategy with Intracavernosal Implantation of Adipose-derived Stem Cells and Daily Oral L-arginine Optimize Recovery of and Cavernosal Functions after Cavernous Nerve Injury in Rats (#050)
Speaker:
Didem Yilmaz-Oral
2:30 PM - 2:35 PM
Differences in the Gut Microbiome Composition Between Men with Erectile Dysfunction and A Matched Cohort: A Pilot Study (#051)
Speaker:
Mohamad M Osman
2:35 PM - 2:40 PM
Leptin Effects on Leydig Stem Cell Differentiation are Specific to Patients BMI (#052)
Speaker:
Kajal Khodamoradi
2:40 PM - 2:45 PM
Low-intensity Extracorporeal Shockwave Therapy as an Adjunct to Xiaflex® in the Treatment of Peyronie’s Disease (#053)
Speaker:
Ayman Soubra
2:45 PM - 2:50 PM
Sonic Hedgehog Signaling in Corpora Cavernosal Cells from Prostatectomy, Diabetic, Hypertension and Peyronie’s Patients with Erectile Dysfunction (#054)
Whole Exome Sequencing Identifies a Rare Mutation in NACAD as a Possible Cause of COVID orchitis in Brothers (#056)
Speaker:
Rohit Reddy
3:00 PM - 3:05 PM
Pathway Enrichment Analysis of Microarray Data from Human Penis of Diabetic and Peyronie’s Patients, in Comparison with Diabetic Rat Erectile Dysfunction Models (#057)
Speaker:
Timothy Searl
3:05 PM - 3:10 PM
Treatment with levothyroxine and testosterone ameliorated erectile dysfunction in rat model of propylthiouracil-induced hypothyroidism (#058)
Speaker:
Fatmanur Korkmaz
1:30 PM - 3:30 PM
Kierland Grand Ballroom 1AB
Peyronie's Disease Abstract Session
Moderators:
Mike Hsieh, MD & Yooni Yi, MD
1:30 PM - 1:40 PM
Collagenase Clostridium Histolyticum Treatment for Peyronie’s Disease: Analysis of Outcomes and Cumulative Benefits After Each Injection Cycle (#059)
Speaker:
Matthew Ziegelmann, MD
1:40 PM - 1:50 PM
Improved Peyronie’s Disease Curvature Outcomes Using a More Aggressive Collagenase Technique (#060)
Speaker:
Alissa Tyler
1:50 PM - 2:00 PM
Penile Extra-Tunical Graft Reconstruction of Peyronie's Disease Concavity Deformities (#061)
Speaker:
Linley Diao
2:00 PM - 2:05 PM
Changes in Point of Maximal Curvature During Collagenase Clostridium Histolyticum Injections for Peyronie’s Disease (#062)
Speaker:
Trevor Price
2:05 PM - 2:10 PM
Evaluating Different Low-intensity Extracorporeal Shockwave Therapy Intensities in the Treatment of Peyronie’s Disease in a Rat Model (#063)
Speaker:
Joseph Kim
2:10 PM - 2:15 PM
Development of a Machine Learning Algorithm for at Home Curvature Assessment (#064)
Speaker:
Luke Witherspoon
2:15 PM - 2:20 PM
Standardizing Sonographic Descriptors of Peyronie’s Plaques (#065)
Speaker:
Daniela Haehn
2:20 PM - 2:25 PM
Novel 3D MRI Fusion Penile Imaging Modality for Peyronie's Disease: A Pilot Study (#066)
Speaker:
Joshua Pincus
2:25 PM - 2:30 PM
Postoperative Progress of Modified Grid Incision and Sealing with Collagen Fleece for Treatment of Peyronie’s Disease (#067)
Speaker:
Suntae Ahn
2:30 PM - 2:35 PM
Incidence of Secondary Intervention for Peyronie’s Disease after Collagenase Clostridium Histolyticum (#068)
Speaker:
Sirpi Nackeeran
2:35 PM - 2:40 PM
Xiaflex® Treatment for Peyronie’s Disease May Improve Penile Curvature Degree With No Effect on the Loss on Penile Length in Post-marketing Analysis (#069)
Speaker:
Jacob W. Greenberg
2:40 PM - 2:45 PM
The SAPOC Technique: A Novel Approach Utilizing Multiple Slices Around Point of Maximal Curvature for the Correction of Penile Curvature at the Time of Penile Prosthesis Placement in Patients with Severe Peyronie’s Disease (#070)
Speaker:
Jonathan Clavell-Hernandez, MD
2:45 PM - 2:50 PM
Adult Patient’s Opinions on Surgical Correction of Congenital Penile Curvature (#071)
Speaker:
Matthew Ziegelmann, MD
2:50 PM - 2:55 PM
Eight injections of Collagenase Clostridium Histolyticum May Be Effective in Calcified Plaques (#072)
Speaker:
Isaac Zucker
2:55 PM - 3:00 PM
The Value of the International Index of Erectile Function (IIEF) in Characterizing the Erectile Function in Patients with Peyronie’s Disease (#073)
Speaker:
Jacob W. Greenberg
3:00 PM - 3:05 PM
Does Treating a Penile Plaque with Collagenase Clostridium Histolyticum Lead to Changes in Vascular Characteristics? (#074)
Speaker:
Ayman Soubra
3:05 PM - 3:10 PM
Peyronie’s Disease: Identification of Patients Requiring Additional Therapy (#075)
Speaker:
Niki Parikh
3:10 PM - 3:15 PM
A Majority of Cases of Peyronie’s Disease Exist in High-Risk Pedigrees (#076)
Speaker:
Ben Christiansen
3:15 PM - 3:20 PM
Verapamil for Peyronie’s Disease: A Systematic Review and Meta-analysis of Effectiveness and Patient Reported Outcomes (#077)
Speaker:
Alvin Christopher Lavadia
3:20 PM - 3:25 PM
CT Imaging of Complex Calcified Peyronie’s Disease (#078)
Speaker:
Christian Ericson
3:25 PM - 3:30 PM
Outcomes of Collagenase Clostridium Histolyticum in Men with Congenital Penile Curvature (#079)
Speaker:
Holli Burgon
3:30 PM - 4:00 PM
Vista Morada Patio
Coffee Break
3:30 PM - 4:00 PM
Foyer - E-poster Station 1
Female Sexual Function/Miscellaneous E-poster Session
Moderator:
Ashley Winter, MD
3:30 PM - 3:33 PM
Preliminary Results From a Multicenter Study on the Use of a New Device for the Treatment of Genito Pelvic Pain Disorders (#205)
Finasteride and Psychiatric Issues and Suicidality - What's the Data?
Speaker:
Alexander Tatem, MD
4:09 PM - 4:18 PM
Impact of In-office BPH Procedures on Ejaculatory Function
Speaker:
Dean Elterman, MD, MSc, FRCSC
4:18 PM - 4:27 PM
How to Best Preserve Sexual Function in Men with Large Prostates
Speaker:
Charles Welliver, MD
4:27 PM - 4:36 PM
AUS Considerations in Men with Prior IPP Placement
Speaker:
O. Lenaine Westney, MD
4:36 PM - 4:45 PM
AUS - What Does the Future Look Like?
Speaker:
Brian Christine, MD
4:45 PM - 4:54 PM
Role of Testosterone in Urethral Reconstructive Surgery
Speaker:
Billy Cordon, MD
4:54 PM - 5:03 PM
Urethroplasty and Sexual Function
Speaker:
Benjamin Breyer, MD
5:03 PM - 5:12 PM
Mid-urethral Slings and Female Sexual Dysfunction
Speaker:
Nicole Szell, DO
5:12 PM - 5:21 PM
Effects of Bowel and Urinary Incontinence on a Couple's Sexuality
Speaker:
Anne Pelletier Cameron, MD
5:21 PM - 5:30 PM
Q&A
4:00 PM - 5:30 PM
Kierland Grand Ballroom 1AB
Erectile Dysfunction Medical Abstract Session
Moderators:
Helen Bernie, DO, MPH & Bruce Kava, MD
4:00 PM - 4:10 PM
Does the Risk of Obstructive Sleep Apnea (OSA) Affect Erectile Function Recovery (EFR) After Radical Prostatectomy (RP)? (#080)
Speaker:
Jose Miguel Flores Martinez
4:10 PM - 4:20 PM
Assessing Online Symptom Checker Accuracy in Diagnosing Men’s Health Conditions (#081)
Speaker:
Rutul Patel
4:20 PM - 4:30 PM
Utility of Ceramide Testing in Men with Erectile Dysfunction (#082)
Speaker:
Manaf Alom
4:30 PM - 4:40 PM
Virtual Intracavernosal Injection Training During the COVID Pandemic (#083)
Speaker:
Christine Zarowski
4:40 PM - 4:45 PM
Evaluating the Impact of Time Between Radical Prostatectomy (RP) and Adjuvant Radiation Therapy (RT) on Erectile Function Recovery (EFR) (#084)
Speaker:
Jose Miguel Flores Martinez
4:45 PM - 4:50 PM
Effect of Stem Cell Infusion Therapy on Sexual Function in Men and Women with Type 2 Diabetes and Metabolic Syndrome: Results from the ACESO & CERES Clinical Trials (#085)
Speaker:
Russell Saltzman
4:50 PM - 4:55 PM
Direct-to-Consumer vs. Traditional Prescriptions of PDE5 inhibitors: A Contemporary Cost-Analysis (#086)
Speaker:
Douglas Schneider
4:55 PM - 5:00 PM
Vascular and Erectile Tissue Health Changes Pre- and Post- Low Intensity Shockwave Treatment of the Erect Penis (#087)
Speaker:
Maria Uloko, MD
5:00 PM - 5:05 PM
Lidocaine Incorporated Alprostadil-phentolamine Urethral Gel for Erectile Dysfunction: Patient Tolerability and Satisfaction (#088)
Speaker:
Rachel Pham
5:05 PM - 5:10 PM
Are There Differences in Stretched Flaccid Penile Length Versus Erectile Penile Length in Men with Erectile Dysfunction? (#089)
Speaker:
Jose Miguel Flores Martinez
5:10 PM - 5:15 PM
A Comparison of the Psychosocial Impact of Penile Prosthesis and Intracavernosal Injection Therapy for Erectile Dysfunction Using the Self-Esteem and Relationship (SEAR) Questionnaire (#090)
Speaker:
Taylor Tidwell
5:15 PM - 5:20 PM
Impact of Neoadjuvant Androgen Deprivation Therapy (NADT) on Erectile Function Recovery (EFR) after Radical Prostatectomy (RP) (#091)
Speaker:
Jose Miguel Flores Martinez
5:20 PM - 5:25 PM
Presence and Etiology of Erectile Dysfunction in Peyronie’s Disease as Demonstrated by Color Doppler Duplex Ultrasound (#092)
Speaker:
Daniela Haehn
4:00 PM - 5:30 PM
Trailblazers Ballroom DE
Cancer Survivorship, Mental Health and Miscellaneous Abstract Session
Moderators:
Brian Le & Daniel Watter, PhD
4:00 PM - 4:10 PM
Acceptance and Commitment Therapy to Increase Compliance to Intracavernosal Injection Use (ICI) Following Radical Prostatectomy (RP): Preliminary Results from a Randomized Control Trial (#093)
Speaker:
Christian Nelson, PhD
4:10 PM - 4:20 PM
Anabolic-Androgenic Steroid Use is Associated with Major Depressive Disorder and Suicide Attempt: Analysis of a Multi-National Database (#094)
Speaker:
Mehul Patel
4:20 PM - 4:30 PM
Initial Validation of the Radical Prostatectomy Questionnaire (RPQ): A New Patient Reported Outcome (PRO) to Assess Sexual Function following Radical Prostatectomy (RP) (#095)
Speaker:
Christian Nelson, PhD
4:30 PM - 4:35 PM
TASHRA’s Core Competencies: The Development and Introduction of Clinical Competencies for the Treatment of Kink Populations (#096)
Speaker:
Stephen Ratcliff
4:35 PM - 4:40 PM
Efficacy of RestoreX Penile Traction Therapy in Improving Penile Length and Erectile Function Post Prostatectomy (#097)
Speaker:
Andrew Zganjar
4:40 PM - 4:45 PM
Patient Perspectives of the Implementation of a Prostate Cancer Survivorship Clinic: A Pilot Qualitative Analysis (#098)
Speaker:
George Koch
4:45 PM - 4:50 PM
Comparison of Sexual Concerns Between Patients with Prostate Cancer and Their Partners (#099)
Speaker:
John Mulhall, MD
4:50 PM - 4:55 PM
Sexual Health Problems and Their Association with Psychological Distress: Investigating the Role of Dyadic Coping Behaviors among Young Adult Breast Cancer Survivors and Partners (#100)
Speaker:
Chiara Acquati, PhD, MSW
4:55 PM - 5:00 PM
Penile Prosthesis Utilization After Radical Cystoprostatectomy for Bladder Cancer (#101)
Speaker:
Megan Prunty
5:00 PM - 5:05 PM
Assessment of Work-Related Musculoskeletal Pain in Urologic Microsurgeons (#102)
Speaker:
Douglas Schneider
5:05 PM - 5:10 PM
Testicular Microlithiasis Defines a Subgroup of Azoospermic Men with Low Rates of Sperm Retrieval (#103)
Speaker:
Snir Dekalo
5:10 PM - 5:15 PM
Reporting of Level 1 Evidence in Peyronie’s Disease Publications- A Systematic Review (#104)
Speaker:
Raevti Bole
5:15 PM - 5:20 PM
Efficacy and Safety of Hyaluronic Acid Filler Injection as Compared to Polylactic Acid Filler for Temporary Penile Augmentation: A Multi-center, Patient/evaluator-blinded, Randomized Control Trial with a Safety Extension. (#105)
Speaker:
Suntae Ahn
5:20 PM - 5:25 PM
Premenstrual Dysphoric Disorder on Youtube: a Quality Analysis (#106)
Speaker:
Mariam Kyarunts
5:25 PM - 5:30 PM
Outcomes for Chronic Pelvic and Genital Pain Using Through an Interdisciplinary Pain Rehabilitation Program (#107)
Speaker:
Reza Roshandel
5:30 PM - 6:00 PM
Kierland Grand Ballroom 4
SMSNA Business Meeting (members only)
6:00 PM - 7:00 PM
Vista Morada Patio
Young Clinicians Mixer
Saturday, October 23, 2021
7:00 AM - 8:00 AM
Kierland Grand Ballroom 4
Industry Sponsored Breakfast Symposium
8:00 AM - 10:00 AM
Kierland Grand Ballroom 2
Updates on Penile Prosthesis Surgery
Moderators:
Culley Carson, MD, John Mulcahy, MD, PhD, Sung Hun Park, MD & Steven Wilson, MD
8:00 AM - 8:09 AM
Eligibility For and Ethics of Denying IPP to Patients
Speaker:
Christian Nelson, PhD
8:09 AM - 8:18 AM
Assessing Patient Satisfaction with IPP Surgery
Speaker:
Carolyn Salter, MD
8:18 AM - 8:27 AM
Treating the IPP Patient's Female Partner with Dyspareunia
Speaker:
Ashley Winter, MD
8:27 AM - 8:36 AM
From Prostatectomy to IPP Placement, A Novel Algorithm
Speaker:
Paul Perito, MD
8:36 AM - 8:45 AM
Pump it Up! A Comparison of Various Pumps
Speaker:
Justin Parker, MD
8:45 AM - 8:54 AM
Novel Strategies for the Management of Common Non-infectious IPP Complications
Speaker:
Jonathan Clavell-Hernandez, MD
8:54 AM - 9:03 AM
Diabetes and IPP Infections: Making Sense of Conflicting Evidence
Speaker:
Faysal Yafi, MD, FRCSC
9:03 AM - 9:12 AM
IPP Salvage in 2021
Speaker:
Aaron Lentz, MD
9:12 AM - 9:21 AM
IPP Improvements - What's in the Pipeline?
Speaker:
Sevann Helo, MD
9:21 AM - 9:46 AM
Head-scratchers! Roundtable Management of Complex IPP Cases
Does Revision Without Replacement Increase Infection Risk in Urologic Prosthetics? (#112)
Speaker:
Scott P. Campbell
2:10 PM - 2:15 PM
Expedited algorithm for IPP following Radical Prostatectomy (#113)
Speaker:
Alfredo Suarez-Sarmiento, Jr.
2:15 PM - 2:20 PM
Patient Risk Factors for Prolonged Opioid Dependence Following Primary Inflatable Penile Prosthesis Placement Managed with Multimodal Analgesia (#114)
Speaker:
Avery Braun
2:20 PM - 2:25 PM
Two Cases of “Drained and Retained” Inflatable Penile Prosthesis and Artificial Urinary Sphincter Reservoirs causing Small Bowel Obstruction (#115)
Speaker:
Justin Loloi
2:25 PM - 2:30 PM
Dorsal Artery Branches to the Corpora Cavernosa (#116)
Speaker:
James Trussler
2:30 PM - 2:35 PM
Erosion of Inflatable Penile Prosthesis with Prolonged Foley Catheterization in the COVID-19 Era (#117)
2:35 PM - 2:40 PM
Does Irrisept Dipping/Irrigation Adversely Affect the Hydrophilic Coating of Titan Implants? (#118)
Speaker:
Ryan Griggs
2:40 PM - 2:45 PM
Current Practices in High and Low Volume Centers Regarding Corporotomy Localization During Penoscrotal Inflatable Penile Implant Surgery (#119)
Speaker:
John Barnard
2:45 PM - 2:50 PM
Does Partner Involvement Reduce Unanticipated Postop Visits Following Penile Prosthesis? (#120)
Speaker:
Amanda Swanton
2:50 PM - 2:55 PM
Factors Associated With Inflatable Penile Prosthesis Underutilization After Prostate Cancer Treatment (#121)
Speaker:
George Abdelmalek
2:55 PM - 3:00 PM
Increasing Utilization of Outpatient Surgery for Inflatable Penile Prosthesis Placement: Contemporary Data from the National Surgical Quality Improvement Program Database (#122)
Speaker:
Thomas Max Shelton
3:00 PM - 3:05 PM
Patient Perception, Rather Than Magnitude of Objective Improvement, Predicts Desire for Treatment Amongst Men Undergoing Penile Shockwave Therapy (#123)
Speaker:
Danly Omil-Lima
3:05 PM - 3:10 PM
Immediate Salvage with Inflatable Penile Prosthesis in an Infected Field: A Contemporary Multi-institutional Cohort (#124)
Speaker:
Daniel Jiang
3:10 PM - 3:15 PM
Extrinsic Compression of Inflatable Penile Prosthesis Secondary to Prone Positioning for COVID-19 Pneumonia: A Case Series of Two Patients (#125)
Speaker:
Carol Feng
3:15 PM - 3:20 PM
Hypertension and Low Cholesterol as Risk Factors for Infection after Penile Prosthesis Surgery (#126)
Speaker:
Justin Loloi
3:20 PM - 3:25 PM
Penile Prosthesis Now An In office Procedure: A Single Center Experience In The US (#127)
Speaker:
Tariq S. Hakky
3:25 PM - 3:30 PM
Perioperative Morbidity of Penile Prosthesis Placement with Concurrent Surgery: Analysis of the National Surgical Quality Improvement Program Database (#128)
Moderators:
Marc Rogers, MD & Hossein Sadeghi-Nejad, MD, FACS
1:30 PM - 1:40 PM
Anal Sex and Sexual Function Satisfaction: A Comprehensive (and Critical) Review of Current Medical Literature (#129)
Speaker:
Alice Walton
1:40 PM - 1:50 PM
Risk Factors for Post-Vasectomy Semen Analysis Non-Adherence in Home-based and Local Lab-based Testing (#130)
Speaker:
Jacob Zipkin
1:50 PM - 1:55 PM
Ejaculation Profiles in Men after Irreversible Electroporation for Prostate Cancer (#131)
Speaker:
Jose Miguel Flores Martinez
1:55 PM - 2:00 PM
Hematospermia and Its Sexual Ramifications: A Systematic Review (#132)
Speaker:
Rob Drury
2:00 PM - 2:05 PM
Pelvic Floor HIFEM in Men Improves Ejaculation (#133)
Speaker:
Judson Brandeis
2:05 PM - 2:10 PM
Prevalence of Sexual Dysfunction in Parkinsonian Men: A Literature Review (#134)
Speaker:
Yousef Rafati
2:10 PM - 2:15 PM
Impedance Rates for Novel Bipolar Radiofrequency Sealing Tool for Transdermal Vasectomy: A Rabbit Model (#135)
Speaker:
Tariq S. Hakky
2:15 PM - 2:20 PM
Small Diameter Penile Implants: A Survey on Current Utilization and Review of Literature (#136)
Speaker:
Scott Campbell
2:20 PM - 2:25 PM
Proper Circumferential Sizing of Penile Implants (#137)
Speaker:
Alfredo Suarez-Sarmiento, Jr.
2:25 PM - 2:30 PM
Is Reddit a Reliable Source for Information on Erectile Dysfunction Treatment? (#138)
Speaker:
Nicholas Sellke
2:30 PM - 2:35 PM
Concerns About Fertility Found to Be Major Cause Of COVID-19 Vaccine Hesitancy in the United States (#139)
Speaker:
Parris Diaz
2:35 PM - 2:40 PM
COVID-19 is Associated with New Onset Erectile Dysfunction: Insights From a Multinational Registry (#140)
Speaker:
Kevin Chu
2:40 PM - 2:45 PM
Association of Poly-tobacco Use with Erectile Dysfunction: Findings from the Population Assessment of Tobacco and Health (PATH) Study (#141)
Speaker:
Omer Raheem, MD
2:45 PM - 2:50 PM
The Efficacy of Written Symptom Questionnaires for the Management of Erectile Dysfunction (#142)
Speaker:
Rohan Bhalla
2:50 PM - 2:55 PM
User Characteristics of Unique Men’s Health Website (#143)
Speaker:
Manaf Alom
2:55 PM - 3:00 PM
Analyzing the Impact of Diabetes on Erectile Function Recovery After Radical Prostatectomy (#144)
Speaker:
Jose Miguel Flores Martinez
3:00 PM - 3:05 PM
Testing a Transdermal Nitric Oxide Booster With a Novel Technology to Quantify Total Penile Vascularity and Volume Using Tissue Segmentation Technology Applied to Ultrasound (#145)
Speaker:
Judson Brandeis
3:05 PM - 3:10 PM
What´s Up With Our Patients 3 Years After Finishing Penile Rehabilitation Study Programs and 5 Years After nsRP? (#146)
Speaker:
Andreas Bannowsky
3:10 PM - 3:15 PM
Critical Underdiagnosis and Undertreatment of Sexual Health Issues in Male Kidney Transplant Recipients (#147)
Speaker:
Alvaro Santamaria
3:15 PM - 3:20 PM
Racial Disparities in Sexual Health Care Received by Kidney Transplant Recipients in a Metropolitan Area (#148)
Speaker:
Alvaro Santamaria
3:30 PM - 4:00 PM
Vista Morada Patio
Coffee Break
3:30 PM - 4:00 PM
Foyer - E-poster Station 1
Erectile Dysfunction Surgical E-poster Session
Moderator:
Sherita King, MD
3:30 PM - 3:33 PM
The Clinical Significance of Imperfection: Do Asymmetry or Occult Curvature Matter in Penile Prosthesis Placement? (#227)
Reservoir Distance from Critical Pelvic Structures: Radiographic Comparison of High Submuscular and Space of Retzius Inflatable Penile Prosthesis Placement Techniques (#228)
Moderators:
Maurice Garcia, MD, MAS & Jonathan Warner, MD
4:00 PM - 4:10 PM
Medical, Gender Dysphoria, and Quality-of-Life Benefits of Pre-Vaginoplasty Bilateral Orchiectomy (#149)
Speaker:
Robert Victor
4:10 PM - 4:20 PM
When to Suspect Artificial Urinary Sphincter Cuff Erosion: An Analysis of Presenting Signs and Symptoms (#150)
Speaker:
Linley Diao
4:20 PM - 4:30 PM
Factors that Drive Patient Satisfaction in Early Recovery Period After Minimally Invasive Surgical Therapy (MIST) for BPH: a Sub-Analysis of PUL and Rezum (#151)
Speaker:
William Schiff
4:30 PM - 4:35 PM
Effectiveness of Pudendal Nerve Blocks on Postoperative Pain Control and Reduction in Opioid Usage after Gender-affirming Vaginoplasty (#152)
Speaker:
Patrick Chin
4:35 PM - 4:40 PM
Gender-Affirming Vaginoplasty: A Patient Perspective on Informational Needs (#153)
Speaker:
Alexi Millman
4:40 PM - 4:45 PM
Post-Phalloplasty Urinary Function Test: A Novel Outcome Instrument to Capture Urinary Dysfunction and Quality of Life after Phalloplasty (#154)
Speaker:
James Liu
4:45 PM - 4:50 PM
Requirement of Mental-health Referral Letters for Staged and Revision Genital Gender-Affirming Surgeries: An Unsanctioned Barrier to Care (#155)
Speaker:
Maurice Garcia, MD, MAS
4:50 PM - 4:55 PM
Where to Draw the Line: Understanding Preferences in Mucosal Collar Length After Circumcision (#156)
Speaker:
Michael Callegari
4:55 PM - 5:00 PM
An Alternative Option for Gender-Affirming Revision Vaginoplasty: The Tubularized Urachus-Peritoneal Hinge Flap (#157)
Speaker:
Maurice Garcia, MD, MAS
5:00 PM - 5:05 PM
Artificial Urinary Sphincter Reverses Weight Gain Associated with Post-Prostatectomy Incontinence (#158)
Speaker:
Raj Bhanvadia
5:05 PM - 5:10 PM
Efficacy, Safety, and Sexual Dysfunction Outcomes of Water Vapor Thermal Therapy (Rezum) in Patients with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: An Updated Systematic Review (#159)
Speaker:
Mustufa Babar
5:10 PM - 5:15 PM
Management of New Complications from Prostatic Urethral Lift (#160)
Speaker:
Tariq S. Hakky
5:15 PM - 5:20 PM
300 Patient Experience with Same Day Surgery for Artificial Urinary Sphincter Insertion - A Safe and Efficient Option (#161)
Speaker:
Benjamin Dropkin
5:20 PM - 5:25 PM
Defining Factors Predictive of Persistent Climacturia After Radical Prostatectomy (#162)
Speaker:
Jose Miguel Flores Martinez
5:30 PM - 6:30 PM
Northern Sky Terrace
APP Networking Session
Sunday, October 24, 2021
7:30 AM - 8:00 AM
Vista Morada Patio
Breakfast
8:00 AM - 9:45 AM
Kierland Grand Ballroom 2
Take Home Messages
Moderators:
Helen Bernie, DO, MPH & Lawrence Jenkins, MD, MBA
8:00 AM - 8:10 AM
Female Sexual Function
Speaker:
Maria Uloko, MD
8:10 AM - 8:20 AM
Male Medical
Speaker:
Aram Loeb, MD
8:20 AM - 8:30 AM
Male Surgical
Speaker:
Thomas Masterson, MD
8:30 AM - 8:40 AM
Peyronie's Disease
Speaker:
John Taylor Barnard, MD
8:40 AM - 8:50 AM
Androgens
Speaker:
Kevin Campbell, MD
8:50 AM - 9:00 AM
Transgender/Reconstruction
Speaker:
Adam Baumgarten, MD
9:00 AM - 9:10 AM
Voiding Dysfunction/Incontinence
Speaker:
Niels Johnson, MD
9:10 AM - 9:20 AM
Basic Science
Speaker:
Joshua Randolph
9:20 AM - 9:30 AM
Mental Health
Speaker:
Chiara Acquati, PhD, MSW
9:45 AM - 10:00 AM
Kierland Grand Ballroom 2
Closing
Non-discussed Video Presentations
Videos
Penile Invagination and Corporal Excavation for Penile Prosthesis Placement in Severe Corporal Fibrosis (#235)
Salvage of Infected Penile Prosthesis using Novel High-Pressure Pulse Irrigation System Adapted to Urological Use in Conjunction with a new Antimicrobial Solution (#241)
Willingham earned her bachelor's degree in English and her PhD in biological sciences at The University of Texas at Austin and completed a postdoctoral fellowship in urology at the University of California-San Francisco. She has taught students of all ages, primarily as a university instructor in scientific writing and biology, focusing on physiology, anatomy, developmental biology, genetics, and general science.
Emily Willingham is author of Phallacy: Life Lessons from the Animal Penis (Avery, 2020) and The Tailored Brain (Basic Books, 2021). Her writing has been published online at the New York Times, Scientific American, Forbes, the San Francisco Chronicle, the Wall Street Journal, Discover, NOVA, Science, and others. She is also co-author with Tara Haelle of the award-winning book, The Informed Parent (Perigee Books/Penguin), and the author of The Complete IG to College Biology. Her writing focuses on the intersection where society, science, and biases meet. She specializes in examining social perspectives on mental health, sexuality and gender, and parenting, with close attention to unconscious motivations and a practical perspective.